Pediatric Gastroenterology, Hepatology & Nutrition

The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition (대한소아소화기영양학회)
권호 표지
DOI QR코드

DOI QR Code

Parenteral Nutrition-Associated Cholestasis in Very Low Birth Weight Infants: A Single Center Experience

  • Kim, Ah-Young (Department of Pediatrics, Pusan National University School of Medicine) ;
  • Lim, Ryoung-Kyoung (Department of Pediatrics, Pusan National University School of Medicine) ;
  • Han, Young-Mi (Department of Pediatrics, Pusan National University School of Medicine) ;
  • Park, Kyung-Hee (Department of Pediatrics, Pusan National University School of Medicine) ;
  • Byun, Shin-Yun (Department of Pediatrics, Pusan National University School of Medicine)
  • Received : 2015.08.13
  • Accepted : 2015.09.15
  • Published : 2016.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Parenteral nutrition (PN)-associated cholestasis (PNAC) is one of the most common complications in very low birth weight infants (VLBWIs). The aim of this study is to evaluate the risk factors of PNAC in VBLWIs. Methods: We retrospectively reviewed the medical records of 322 VLBWIs admitted to the neonatal intensive care unit of our hospital from July 1, 2009 to December 31, 2013. We excluded 72 dead infants; 6 infants were transferred to another hospital, and 57 infants were transferred to our hospital at 2 weeks after birth. The infants were divided into the cholestasis and the non-cholestasis groups. PNAC was defined as a direct bilirubin level of ${\geq}2.0mg/dL$ in infants administered with PN for ${\geq}2weeks$. Results: A total of 187 VLBWI were enrolled in this study; of these, 46 infants developed PNAC. Multivariate logistic regression analysis showed that the risk factors of PNAC in VLBWI were longer duration of antimicrobial use (odds ratio [OR] 4.49, 95% confidence interval [95% CI] 4.42-4.58), longer duration of PN (OR 2.68, 95% CI 2.41-3.00), long-term lack of enteral nutrition (OR 2.89, 95% CI 2.43-3.37), occurrence of necrotizing enterocolitis (OR 2.40, 95% CI 2.16-2.83), and gastrointestinal operation (OR 2.19, 95% CI 2.03-2.58). Conclusion: The results of this study suggest that shorter PN, aggressive enteral nutrition, and appropriate antimicrobial use are important strategies in preventing PNAC.

Keywords

References

  1. Jolin-Dahel K, Ferretti E, Montiveros C, Grenon R, Barrowman N, Jimenez-Rivera C. Parenteral nutrition-induced cholestasis in neonates: where does the problem lie? Gastroenterol Res Pract 2013;2013:163632.
  2. Hsieh MH, Pai W, Tseng HI, Yang SN, Lu CC, Chen HL. Parenteral nutrition-associated cholestasis in premature babies: risk factors and predictors. Pediatr Neonatol 2009;50:202-7. https://doi.org/10.1016/S1875-9572(09)60064-4
  3. McKiernan PJ. Neonatal cholestasis. Semin Neonatol 2002;7:153-65. https://doi.org/10.1053/siny.2002.0103
  4. Hofmann AF. Defective biliary secretion during total parenteral nutrition: probable mechanisms and possible solutions. J Pediatr Gastroenterol Nutr 1995;20: 376-90. https://doi.org/10.1097/00005176-199505000-00002
  5. Chen CY, Chen HL. The risk factors of parenteral nutrition-associated cholestasis in preterm infants. Pediatr Neonatol 2009;50:181-3. https://doi.org/10.1016/S1875-9572(09)60060-7
  6. Choi JS, Bae YJ, Lee YA. Comparison of total parenteral nutrition-associated cholestasis according to amino acid mixtures in very low birth weight infants. Korean J Pediatr 2006;49:972-6. https://doi.org/10.3345/kjp.2006.49.9.972
  7. Whitington PF. Cholestasis associated with total parenteral nutrition in infants. Hepatology 1985;5:693-6. https://doi.org/10.1002/hep.1840050428
  8. Cheung HM, Lam HS, Tam YH, Lee KH, Ng PC. Rescue treatment of infants with intestinal failure and parenteral nutrition-associated cholestasis (PNAC) using a parenteral fish-oil-based lipid. Clin Nutr 2009;28: 209-12. https://doi.org/10.1016/j.clnu.2009.02.004
  9. Brown SJ, Desmond PV. Hepatotoxicity of antimicrobial agents. Semin Liver Dis 2002;22:157-67. https://doi.org/10.1055/s-2002-30103
  10. Kullak-Ublick GA, Stieger B, Hagenbuch B, Meier PJ. Hepatic transport of bile salts. Semin Liver Dis 2000;20:273-92. https://doi.org/10.1055/s-2000-9426
  11. Yoon SJ, Kim CS, Lee SL. Clinical findings of sepsis-associated cholestasis in the neonates. Korean J Pediatr 2004;47:380-5.
  12. Vargas V, Aleman C, de Torres I, Castells L, Gavalda J, Margarit C, et al. Listeria monocytogenes-associated acute hepatitis in a liver transplant recipient. Liver 1998;18:213-5.
  13. Goulet OJ. Intestinal failure-associated liver disease and the use of fish oil-based lipid emulsions. World Rev Nutr Diet 2015;112:90-114.
  14. Aghai ZH, Mudduluru M, Nakhla TA, Amendolia B, Longo D, Kemble N, et al. Fluconazole prophylaxis in extremely low birth weight infants: association with cholestasis. J Perinatol 2006;26:550-5. https://doi.org/10.1038/sj.jp.7211570
  15. Kaufman DA, Morris A, Gurka MJ, Kapik B, Hetherington S. Fluconazole prophylaxis in preterm infants: a multicenter case-controlled analysis of efficacy and safety. Early Hum Dev 2014;90 Suppl 1:S87-90. https://doi.org/10.1016/S0378-3782(14)70026-X
  16. Drongowski RA, Coran AG. An analysis of factors contributing to the development of total parenteral nutrition- induced cholestasis. JPEN J Parenter Enteral Nutr 1989;13:586-9. https://doi.org/10.1177/0148607189013006586
  17. Christensen RD, Henry E, Wiedmeier SE, Burnett J, Lambert DK. Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition- associated liver disease. J Perinatol 2007;27:284-90. https://doi.org/10.1038/sj.jp.7211686
  18. Kim H, Lee JJ, Park SJ, Kim AR, Kim KS, Pi SY. Total parenteral nutrition-associated cholestasis in very low birth weight infants. J Korean Soc Neonatol 2001;8: 200-5.
  19. Jeon GW, Choi CW, Hwang JH, Gu SH, Kim YJ, Lee JH, et al. The risk factors of cholestasis in very low birth weight infants. J Korean Soc Neonatol 2005;12:63-9.
  20. Bolisetty S, Osborn D, Sinn J, Lui K; Australasian Neonatal Parenteral Nutrition Consensus Group. Standardised neonatal parenteral nutrition formulations - an Australasian group consensus 2012. BMC Pediatr 2014;14:48. https://doi.org/10.1186/1471-2431-14-48
  21. Messing B, Colombel JF, Heresbach D, Chazouilleres O, Galian A. Chronic cholestasis and macronutrient excess in patients treated with prolonged parenteral nutrition. Nutrition 1992;8:30-6.
  22. Lloyd DA, Zabron AA, Gabe SM. Chronic biochemical cholestasis in patients receiving home parenteral nutrition: prevalence and predisposing factors. Aliment Pharmacol Ther 2008;27:552-60. https://doi.org/10.1111/j.1365-2036.2008.03615.x
  23. Vileisis RA, Inwood RJ, Hunt CE. Prospective controlled study of parenteral nutrition-associated cholestatic jaundice: effect of protein intake. J Pediatr 1980;96:893-7. https://doi.org/10.1016/S0022-3476(80)80573-7
  24. Kang SJ, Park EK, Park HK, Kim CR, Seol IJ. Effect of low versus high parenteral amino acid supplementation on liver unctions in premature infants. Korean J Perinatol 2010;21:266-72.
  25. Dorvil NP, Yousef IM, Tuchweber B, Roy CC. Taurine prevents cholestasis induced by lithocholic acid sulfate in guinea pigs. Am J Clin Nutr 1983;37:221-32. https://doi.org/10.1093/ajcn/37.2.221
  26. Moran JM, Salas J, Botello F, Macia E, Climent V. Taurine and cholestasis associated to TPN. Experimental study in rabbit model. Pediatr Surg Int 2005;21: 786-92. https://doi.org/10.1007/s00383-005-1541-3
  27. Lee HY, Lee GY, Kim MJ, Jeon GW, Shim JW, Chang YS, et al. The effect of early enteral trophic feeding within 24 hours after birth in extremely low birth weight infants of 26 weeks and less, and birth weight below 1,000 g. J Korean Soc Neonatol 2007;14:59-65.
  28. Loomis T, Byham-Gray L, Ziegler J, Parrott JS. Impact of standardized feeding guidelines on enteral nutrition administration, growth outcomes, metabolic bone disease, and cholestasis in the NICU. J Pediatr Gastroenterol Nutr 2014;59:93-8. https://doi.org/10.1097/MPG.0000000000000314
  29. Park KP, Kim SY, Kim HM. Total parenteral nutrition-associated cholestasis in premature infants. J Korean Pediatr Soc 2003;46:17-23.
  30. Veenstra M, Danielson L, Brownie E, Saba M, Natarajan G, Klein M. Enteral nutrition and total parenteral nutrition components in the course of total parenteral nutrition-associated cholestasis in neonatal necrotizing enterocolitis. Surgery 2014;156:578-83. https://doi.org/10.1016/j.surg.2014.04.031

Cited by

  1. Parenteral Nutrition-associated Liver Disease vol.8, pp.1, 2016, https://doi.org/10.18858/smn.2017.8.1.7
  2. Risk factors of parenteral nutrition‐associated cholestasis in very‐low‐birthweight infants vol.56, pp.11, 2016, https://doi.org/10.1111/jpc.14826